1,842 Shares in Simulations Plus, Inc. (NASDAQ:SLP) Bought by Quantbot Technologies LP

Quantbot Technologies LP bought a new stake in Simulations Plus, Inc. (NASDAQ:SLP) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 1,842 shares of the technology company’s stock, valued at approximately $59,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. First Horizon Advisors Inc. increased its holdings in shares of Simulations Plus by 82.6% in the 3rd quarter. First Horizon Advisors Inc. now owns 818 shares of the technology company’s stock valued at $26,000 after acquiring an additional 370 shares during the last quarter. nVerses Capital LLC increased its stake in Simulations Plus by 1,100.0% in the third quarter. nVerses Capital LLC now owns 1,200 shares of the technology company’s stock valued at $38,000 after purchasing an additional 1,100 shares during the last quarter. US Bancorp DE increased its stake in Simulations Plus by 37.0% in the third quarter. US Bancorp DE now owns 4,974 shares of the technology company’s stock valued at $159,000 after purchasing an additional 1,343 shares during the last quarter. Los Angeles Capital Management LLC acquired a new stake in Simulations Plus during the second quarter worth approximately $206,000. Finally, Pitcairn Co. lifted its position in shares of Simulations Plus by 9.1% during the 3rd quarter. Pitcairn Co. now owns 6,599 shares of the technology company’s stock worth $211,000 after buying an additional 549 shares during the last quarter. 78.08% of the stock is currently owned by institutional investors and hedge funds.

Simulations Plus Trading Up 0.7 %

NASDAQ:SLP opened at $30.13 on Friday. Simulations Plus, Inc. has a 12-month low of $27.07 and a 12-month high of $51.22. The stock’s 50 day simple moving average is $30.79 and its 200-day simple moving average is $36.98. The firm has a market cap of $604.62 million, a P/E ratio of 61.49 and a beta of 0.76.

Simulations Plus (NASDAQ:SLP) last announced its quarterly earnings data on Wednesday, October 23rd. The technology company reported $0.06 EPS for the quarter, topping analysts’ consensus estimates of $0.04 by $0.02. Simulations Plus had a net margin of 14.15% and a return on equity of 6.16%. The company had revenue of $18.70 million during the quarter, compared to the consensus estimate of $19.73 million. During the same quarter in the prior year, the firm earned $0.18 EPS. Simulations Plus’s quarterly revenue was up 19.9% on a year-over-year basis. Research analysts forecast that Simulations Plus, Inc. will post 1.1 EPS for the current fiscal year.

Insider Buying and Selling at Simulations Plus

In other news, Director Walter S. Woltosz sold 20,000 shares of the company’s stock in a transaction on Friday, November 1st. The shares were sold at an average price of $27.66, for a total transaction of $553,200.00. Following the transaction, the director now directly owns 3,462,584 shares of the company’s stock, valued at $95,775,073.44. This represents a 0.57 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In the last 90 days, insiders have sold 60,750 shares of company stock valued at $1,837,255. 20.90% of the stock is owned by corporate insiders.

Wall Street Analysts Forecast Growth

SLP has been the topic of several research analyst reports. William Blair reiterated an “outperform” rating on shares of Simulations Plus in a research note on Wednesday, November 6th. Stephens initiated coverage on Simulations Plus in a research report on Friday, November 15th. They set an “overweight” rating and a $39.00 target price on the stock. StockNews.com cut Simulations Plus from a “hold” rating to a “sell” rating in a research report on Monday, November 4th. Finally, BTIG Research cut their price target on Simulations Plus from $60.00 to $50.00 and set a “buy” rating on the stock in a research report on Thursday, October 24th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $51.40.

Simulations Plus Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.